AviadoBio is based in London, United Kingdom. It has raised $97M in total funding. Latest round: Series A.
AviadoBio funding overview
AviadoBio is based in London, United Kingdom. AviadoBio has raised $97M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for AviadoBio runs through 2021; nothing later has been disclosed. Investors on record include New Enterprise Associates (NEA), Monograph Capital, LSP, Advent Life Sciences, Dementia Discovery Fund (DDF), F-Prime Capital and 2 others. 8 distinct backers are named across the disclosed rounds.
AviadoBio at a glance
Total raised
$97M
Latest round
Series A
Latest round date
December 2021
Headquarters
London, United Kingdom
Notable investors
New Enterprise Associates (NEA), Monograph Capital, LSP, Advent Life Sciences, Dementia Discovery Fund (DDF), F-Prime Capital, Johnson & Johnson Innovation – JJDC, Inc. (JJDC), LifeArc
Frequently asked about AviadoBio funding
How much has AviadoBio raised?
AviadoBio has raised $97M in total disclosed funding across the rounds on record.
Who has invested in AviadoBio?
New Enterprise Associates (NEA), Monograph Capital, LSP, Advent Life Sciences, Dementia Discovery Fund (DDF), F-Prime Capital are named among the investors backing AviadoBio.
What was the latest AviadoBio funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is AviadoBio based?
AviadoBio is based in London, United Kingdom.
When did AviadoBio last raise?
The last disclosed AviadoBio round closed in December 2021 at Series A.
AviadoBio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in London below to benchmark round size and investor mix.
